These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6001062)

  • 21. Albumin binding and hydrophobic character of promazine and chlorpromazine metabolites.
    Kriegelstein J; Lier F; Michaelis J
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(2):121-30. PubMed ID: 4258285
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions.
    Hollister LE; Curry SH
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):330-8. PubMed ID: 4948435
    [No Abstract]   [Full Text] [Related]  

  • 23. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.
    Curry SH
    Proc R Soc Med; 1971 Mar; 64(3):285-9. PubMed ID: 5551485
    [No Abstract]   [Full Text] [Related]  

  • 24. Direct, multiple ion detection of chlorpromazine by mass fragmentography.
    Green DE
    Adv Biochem Psychopharmacol; 1974; 9(0):119-29. PubMed ID: 4836202
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of promazine and chlorpromazine metabolites on the cornea.
    Adams HR; Manian AA; Steenberg ML; Buckley JP
    Adv Biochem Psychopharmacol; 1974; 9(0):281-93. PubMed ID: 4836207
    [No Abstract]   [Full Text] [Related]  

  • 26. [Electric interphasic blood potential for sodium and potassium ions in patients treated with chlorpromazine for various mental disorders].
    Bichoński R
    Psychiatr Pol; 1972; 6(2):131-6. PubMed ID: 5027437
    [No Abstract]   [Full Text] [Related]  

  • 27. [Palladometric determination of phenothiazines in biological material].
    Tasić-Brdović J; Stojanović L; Jovanović D
    Vojnosanit Pregl; 1981; 38(5):350-2. PubMed ID: 7324393
    [No Abstract]   [Full Text] [Related]  

  • 28. [Uptake of phenothiazine derivatives by the isolated perfused rat brain].
    Krieglstein J; Jähnchen E
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):380-1. PubMed ID: 4253813
    [No Abstract]   [Full Text] [Related]  

  • 29. Side-chain degradation and ring hydroxylation of pehnothiazine tranquilizers.
    Fishman V; Goldenberg H
    J Pharmacol Exp Ther; 1965 Oct; 150(1):122-8. PubMed ID: 5853692
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydrophobic character of phenothiazine derivatives as determining factor for their initial uptake by the isolated perfused rat liver].
    Jähnchen E; Krieglstein J; Kunkel F; Samuelis WJ
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):363-4. PubMed ID: 4254339
    [No Abstract]   [Full Text] [Related]  

  • 31. [Labeling method in the study of the fate of two phenothiazine derivatives in the organism; S35-labeled aminazine and promazine].
    FEDOROV NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(2):137-49. PubMed ID: 13605119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of a new neuroplegic drug, Dixyrazine, in a double-blind experiment with subsequent serial analysis].
    Bensch K; Rundberg B
    Wien Z Nervenheilkd Grenzgeb; 1965; 22(3):217-24. PubMed ID: 4222763
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the penetration of aminazine into the central nervous system].
    Maĭzelis MIa; Kuznetsova VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):431-6. PubMed ID: 5795731
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cerebral and hepatic fixation of phenothiazine and iminodibenzyl derivatives in rats].
    Stephan Y; Welin L; Mainard F
    C R Acad Hebd Seances Acad Sci D; 1972 Sep; 275(10):1087-9. PubMed ID: 4629719
    [No Abstract]   [Full Text] [Related]  

  • 35. [FORRESTS' TEST AS A CONTROL DEVICE IN THE USE OF PSYCHOTROPIC DRUGS WITH OBSERVATIONS ON THE RESULTS OF CONTROL].
    ROGOWSKA J
    Neurol Neurochir Psychiatr Pol; 1964; 14():153-8. PubMed ID: 14196357
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism and excretion of promazine by the horse.
    Weir JJ; Sanford J
    J Pharm Pharmacol; 1969 Mar; 21(3):169-75. PubMed ID: 4388212
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of aminazine and tofranil on the feeding behavior of dogs both normal subjects and those with experimental neuroses].
    Levtova FA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1658-66. PubMed ID: 6012131
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic porphyria with mental symptoms. Four missed cases.
    Carney MW
    Lancet; 1972 Jul; 2(7768):100-1. PubMed ID: 4113890
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biopharmaceutical evaluation of aminazine accumulation in the rat liver and brain].
    Kovaleva NS; Tentsova AI; Ladygina GA; Ivkov NN
    Farmatsiia; 1978; 27(1):31-4. PubMed ID: 631351
    [No Abstract]   [Full Text] [Related]  

  • 40. Dichlorpromazine, chlorpromazine, chlordiazepoxide in psychiatric out-patients (comparative controlled study).
    Vinar O; Hausner M; Scudlík M; Horanská D; Tautermann P
    Act Nerv Super (Praha); 1965 Aug; 7(3):300-1. PubMed ID: 5326946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.